LSE - Delayed Quote USD

Revvity, Inc. (0KHE.L)

100.98

-0.47

(-0.46%)

As of 2:35 PM GMT+1. Market Open.

Revvity Board Declares Quarterly Dividend

WALTHAM, Mass., April 25, 2024--The Board of Directors of Revvity (NYSE: RVTY), today declared a regular quarterly dividend of $0.07 per share of common stock. This dividend is payable on August 9, 2024 to all shareholders of record at the close of business on July 19, 2024.

Business Wire 18 hours ago

RVTY
Revvity's (RVTY) New Launch to Boost Tuberculosis Testing

Revvity's (RVTY) latest offering is likely to provide a new and improved workflow to lower hands-on time and enable increased lab productivity.

Zacks 22 hours ago

RVTY

ECL
Revvity to Present at BofA Securities 2024 Health Care Conference

WALTHAM, Mass., April 25, 2024--Revvity, Inc. (NYSE: RVTY) will present at the BofA Securities 2024 Health Care Conference on Tuesday, May 14, 2024 at 8:40 a.m. PT in Las Vegas, NV.

Business Wire yesterday

RVTY
Revvity Unveils a New Era of Automated Tuberculosis Testing

WALTHAM, Mass., April 24, 2024--Revvity, Inc. (NYSE: RVTY) today announced the launch of the Auto-Pure 2400 liquid handler from Allsheng for use with the T-SPOT.TB test. The Auto-Pure 2400 platform is easy to use and designed to provide efficient workflows in the lab. When the accuracy of the T-SPOT.TB test is combined with the efficiency of the Auto-Pure 2400 system, labs, clinicians and ultimately patients, benefit from the resultant powerful solution.

Business Wire 2 days ago

RVTY
Investors in Revvity (NYSE:RVTY) have unfortunately lost 25% over the last three years

As an investor its worth striving to ensure your overall portfolio beats the market average. But its virtually certain...

Simply Wall St. 3 days ago

RVTY
Revvity's (RVTY) Launch to Boost Pharma-Contract Partner Tie-Up

Revvity's (RVTY) latest offering is likely to significantly accelerate the pace of drug innovation, with efficient data sharing into one seamless platform.

Zacks 9 days ago

RVTY

CAH

DVA
Revvity Signals Software’s New Synergy Solution Redefines Collaboration Between Pharma and Contract Partners

WALTHAM, Mass., April 15, 2024--Today, Revvity, Inc. (NYSE: RVTY) announced that its software and informatics division, Revvity Signals, will launch Signals SynergyTM, a software solution designed to drive greater collaboration, project management, and data exchange between pharmaceutical and biotechnology sponsors with their external contract partners.

Business Wire 11 days ago

RVTY
Revvity (RVTY) Stock Jumps 4.1%: Will It Continue to Soar?

Revvity (RVTY) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.

Zacks 16 days ago

RVTY

PINC
Revvity, Inc. (NYSE:RVTY) is largely controlled by institutional shareholders who own 80% of the company

Key Insights Significantly high institutional ownership implies Revvity's stock price is sensitive to their trading...

Simply Wall St. 20 days ago

RVTY
Revvity To Hold Earnings Call on Monday, April 29, 2024

WALTHAM, Mass., April 04, 2024--Revvity, Inc. (NYSE: RVTY), today announced that it will release its first quarter 2024 financial results prior to market open on Monday, April 29, 2024. The Company will host a conference call the same day at 8:00 a.m. ET to discuss these results. Prahlad Singh, president and chief executive officer, and Max Krakowiak, chief financial officer, will host the conference call.

Business Wire 22 days ago

RVTY
Preliminary Injunction Granted to Enforce Revvity’s Rights and Cloud Software Group’s Obligations Related to Spotfire Software

WALTHAM, Mass., April 02, 2024--Today, Revvity, Inc. (NYSE: RVTY) announced that the Massachusetts Superior Court has granted a preliminary injunction compelling Cloud Software Group (CSG) to comply with its contractual obligations under its strategic partner agreements with Revvity, including an order to cease all marketing, selling and support activities in Revvity’s exclusive markets and to continue delivering maintenance services to Revvity in relation to its Spotfire® software.

Business Wire 24 days ago

RVTY
Three Reasons to Retain Revvity (RVTY) Stock in Your Portfolio

Revvity's (RVTY) strong product portfolio raises optimism about the stock.

Zacks 24 days ago

RVTY

CAH

DVA
Revvity's (RVTY) New Launch to Boost Research Productivity

Revvity's (RVTY) latest next-generation suite is likely to enhance research productivity and innovation.

Zacks last month

RVTY

CAH

DVA
Revvity Files Complaint and Seeks Injunctive Relief Against Cloud Software Group

WALTHAM, Mass., March 20, 2024--Today, Revvity, Inc. (NYSE: RVTY) announced that it has filed a complaint against Cloud Software Group (CSG) in Massachusetts Superior Court and requested injunctive relief to enforce Revvity’s rights and CSG’s obligations as a strategic partner.

Business Wire last month

RVTY
Revvity's (RVTY) New Launch to Boost Newborn Sequencing Research

Revvity's (RVTY) next-generation newborn sequencing research workflow is likely to build the foundation for diagnosing rare diseases in the future.

Zacks last month

RVTY

CAH

DVA
Revvity Signals Software Introduces Signals ChemDraw Offering to Set New Standard for Cloud-Native Chemistry Communication

WALTHAM, Mass., March 18, 2024--Today, Revvity, Inc. (NYSE: RVTY) announced that its software and informatics division, Revvity Signals Software, is introducing the new Signals ChemDraw® offering, the latest advancement in the Revvity Signals Software portfolio. This innovative chemistry suite is set to transform the way researchers in the pharmaceutical and non-pharmaceutical chemical industries, as well as academia, develop and communicate complex chemical concepts and collaborate across disci

Business Wire last month

RVTY
Moderna Looks to Pare R&D Spending Even as It Pivots From Covid Vaccines

The biotech company is advancing new offerings in part to offset revenue declines while also trying to bring costs down.

The Wall Street Journal last month

RVTY

MRNA
Decoding Revvity Inc (RVTY): A Strategic SWOT Insight

Unveiling the Financial and Strategic Landscape of Revvity Inc (RVTY)

GuruFocus.com last month

RVTY
Is Now The Time To Look At Buying Revvity, Inc. (NYSE:RVTY)?

Revvity, Inc. ( NYSE:RVTY ) saw a decent share price growth of 19% on the NYSE over the last few months. While good...

Simply Wall St. 2 months ago

RVTY
Revvity to Present at Upcoming Investor Conferences

WALTHAM, Mass., February 21, 2024--Revvity, Inc. (NYSE: RVTY) today announced it will present at the following investor conferences in February and March 2024:

Business Wire 2 months ago

RVTY

Performance Overview

Return	0KHE.L	MSCI WORLD
YTD	-7.99%	+5.24%
1-Year	-22.62%	+19.56%
3-Year	0.00%	0.00%

News

Life

Entertainment

Finance

Sports

New on Yahoo

Yahoo Finance

Revvity, Inc. (0KHE.L)

Revvity Board Declares Quarterly Dividend

Revvity's (RVTY) New Launch to Boost Tuberculosis Testing

Revvity to Present at BofA Securities 2024 Health Care Conference

Revvity Unveils a New Era of Automated Tuberculosis Testing

Investors in Revvity (NYSE:RVTY) have unfortunately lost 25% over the last three years

Revvity's (RVTY) Launch to Boost Pharma-Contract Partner Tie-Up

Revvity Signals Software’s New Synergy Solution Redefines Collaboration Between Pharma and Contract Partners

Revvity (RVTY) Stock Jumps 4.1%: Will It Continue to Soar?

Revvity, Inc. (NYSE:RVTY) is largely controlled by institutional shareholders who own 80% of the company

Revvity To Hold Earnings Call on Monday, April 29, 2024

Preliminary Injunction Granted to Enforce Revvity’s Rights and Cloud Software Group’s Obligations Related to Spotfire Software

Three Reasons to Retain Revvity (RVTY) Stock in Your Portfolio

Revvity's (RVTY) New Launch to Boost Research Productivity

Revvity Files Complaint and Seeks Injunctive Relief Against Cloud Software Group

Revvity's (RVTY) New Launch to Boost Newborn Sequencing Research

Revvity Signals Software Introduces Signals ChemDraw Offering to Set New Standard for Cloud-Native Chemistry Communication

Moderna Looks to Pare R&D Spending Even as It Pivots From Covid Vaccines

Decoding Revvity Inc (RVTY): A Strategic SWOT Insight

Is Now The Time To Look At Buying Revvity, Inc. (NYSE:RVTY)?

Revvity to Present at Upcoming Investor Conferences

Performance Overview